AIM:To compare XELOX and FOLFOX4 as colon cancer adjuvant chemotherapy based on MOSAIC and No.16968 trails from Chinese cost-effectiveness perspective.METHODS:A
AIM:To establish and validate a simple quantitative assessment method for nonalcoholic fatty liver disease(NAFLD)based on a combination of the ultrasound hepati